- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Insulin Glargine will have significant change from previous year. By the most conservative estimates of global Insulin Glargine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 6040 million in 2019. Over the next five years the Insulin Glargine market will register a 4.1% CAGR in terms of revenue, the global market size will reach US$ 7106.7 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Glargine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Treat Type2 Diabetes
Treat Type1 Diabetes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sanofi-Aventis
Ganlee
Biocon
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Glargine Consumption 2016-2026
2.1.2 Insulin Glargine Consumption CAGR by Region
2.2 Insulin Glargine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 Insulin Glargine Sales by Type
2.3.1 Global Insulin Glargine Sales Market Share by Type (2016-2021)
2.3.2 Global Insulin Glargine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Insulin Glargine Sale Price by Type (2016-2021)
2.4 Insulin Glargine Segment by Application
2.4.1 Treat Type2 Diabetes
2.4.2 Treat Type1 Diabetes
2.5 Insulin Glargine Sales by Application
2.5.1 Global Insulin Glargine Sale Market Share by Application (2016-2021)
2.5.2 Global Insulin Glargine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Insulin Glargine Sale Price by Application (2016-2021)
3 Global Insulin Glargine by Company
3.1 Global Insulin Glargine Sales Market Share by Company
3.1.1 Global Insulin Glargine Sales by Company (2019-2021)
3.1.2 Global Insulin Glargine Sales Market Share by Company (2019-2021)
3.2 Global Insulin Glargine Revenue Market Share by Company
3.2.1 Global Insulin Glargine Revenue by Company (2019-2021)
3.2.2 Global Insulin Glargine Revenue Market Share by Company (2019-2021)
3.3 Global Insulin Glargine Sale Price by Company
3.4 Global Manufacturers Insulin Glargine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Glargine Product Location Distribution
3.4.2 Players Insulin Glargine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Insulin Glargine by Region
4.1 Global Insulin Glargine by Region
4.1.1 Global Insulin Glargine Sales by Region
4.1.2 Global Insulin Glargine Revenue by Region
4.2 Americas Insulin Glargine Sales Growth
4.3 APAC Insulin Glargine Sales Growth
4.4 Europe Insulin Glargine Sales Growth
4.5 Middle East & Africa Insulin Glargine Sales Growth
5 Americas
5.1 Americas Insulin Glargine Sales by Country
5.1.1 Americas Insulin Glargine Sales by Country (2016-2021)
5.1.2 Americas Insulin Glargine Revenue by Country (2016-2021)
5.2 Americas Insulin Glargine Sales by Type
5.3 Americas Insulin Glargine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Glargine Sales by Region
6.1.1 APAC Insulin Glargine Sales by Region (2016-2021)
6.1.2 APAC Insulin Glargine Revenue by Region (2016-2021)
6.2 APAC Insulin Glargine Sales by Type
6.3 APAC Insulin Glargine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Insulin Glargine by Country
7.1.1 Europe Insulin Glargine Sales by Country (2016-2021)
7.1.2 Europe Insulin Glargine Revenue by Country (2016-2021)
7.2 Europe Insulin Glargine Sales by Type
7.3 Europe Insulin Glargine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin Glargine by Country
8.1.1 Middle East & Africa Insulin Glargine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Insulin Glargine Revenue by Country (2016-2021)
8.2 Middle East & Africa Insulin Glargine Sales by Type
8.3 Middle East & Africa Insulin Glargine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Insulin Glargine Distributors
10.3 Insulin Glargine Customer
11 Global Insulin Glargine Market Forecast
11.1 Global Insulin Glargine Forecast by Region
11.1.1 Global Insulin Glargine Forecast by Regions (2021-2026)
11.2.2 Global Insulin Glargine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Insulin Glargine Forecast by Type
11.7 Global Insulin Glargine Forecast by Application
12 Key Players Analysis
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Sanofi-Aventis Company Information
12.1.2 Sanofi-Aventis Insulin Glargine Product Offered
12.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sanofi-Aventis Main Business Overview
12.1.5 Sanofi-Aventis Latest Developments
12.2 Ganlee
12.2.1 Ganlee Company Information
12.2.2 Ganlee Insulin Glargine Product Offered
12.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Ganlee Main Business Overview
12.2.5 Ganlee Latest Developments
12.3 Biocon
12.3.1 Biocon Company Information
12.3.2 Biocon Insulin Glargine Product Offered
12.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Biocon Main Business Overview
12.3.5 Biocon Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Insulin Glargine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Single Dose Vial
Table 3. Major Players of Pre-filled Syringe
Table 4. Global Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 5. Global Insulin Glargine Sales Market Share by Type (2016-2021)
Table 6. Global Insulin Glargine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Insulin Glargine Revenue Market Share by Type (2016-2021)
Table 8. Global Insulin Glargine Sale Price by Type (2016-2021)
Table 9. Global Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 10. Global Insulin Glargine Sales Market Share by Application (2016-2021)
Table 11. Global Insulin Glargine Value by Application (2016-2021)
Table 12. Global Insulin Glargine Revenue Market Share by Application (2016-2021)
Table 13. Global Insulin Glargine Sale Price by Application (2016-2021)
Table 14. Global Insulin Glargine Sales by Company (2019-2021) & (M mL)
Table 15. Global Insulin Glargine Sales Market Share by Company (2019-2021)
Table 16. Global Insulin Glargine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Insulin Glargine Revenue Market Share by Company (2019-2021)
Table 18. Global Insulin Glargine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Insulin Glargine Producing Area Distribution and Sales Area
Table 20. Players Insulin Glargine Products Offered
Table 21. Insulin Glargine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Insulin Glargine Sales by Region (2016-2021) (M mL)
Table 25. Global Insulin Glargine Sales Market Share by Region (2016-2021)
Table 26. Global Insulin Glargine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Insulin Glargine Revenue Market Share by Region (2016-2021)
Table 28. Americas Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 29. Americas Insulin Glargine Sales Market Share by Country (2016-2021)
Table 30. Americas Insulin Glargine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 32. Americas Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 33. Americas Insulin Glargine Sales Market Share by Type (2016-2021)
Table 34. Americas Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 35. Americas Insulin Glargine Sales Market Share by Application (2016-2021)
Table 36. APAC Insulin Glargine Sales by Region (2016-2021) & (M mL)
Table 37. APAC Insulin Glargine Sales Market Share by Region (2016-2021)
Table 38. APAC Insulin Glargine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Insulin Glargine Revenue Market Share by Region (2016-2021)
Table 40. APAC Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 41. APAC Insulin Glargine Sales Market Share by Type (2016-2021)
Table 42. APAC Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 43. APAC Insulin Glargine Sales Market Share by Application (2016-2021)
Table 44. Europe Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 45. Europe Insulin Glargine Sales Market Share by Country (2016-2021)
Table 46. Europe Insulin Glargine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 48. Europe Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 49. Europe Insulin Glargine Sales Market Share by Type (2016-2021)
Table 50. Europe Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 51. Europe Insulin Glargine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Insulin Glargine Sales by Country (2016-2021) & (M mL)
Table 53. Middle East & Africa Insulin Glargine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Insulin Glargine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Insulin Glargine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Insulin Glargine Sales by Type (2016-2021) & (M mL)
Table 57. Middle East & Africa Insulin Glargine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Insulin Glargine Sales by Application (2016-2021) & (M mL)
Table 59. Middle East & Africa Insulin Glargine Sales Market Share by Application (2016-2021)
Table 60. Global Insulin Glargine Sales Forecast by Type (2021-2026) & (M mL)
Table 61. Global Insulin Glargine Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Insulin Glargine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Insulin Glargine Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Insulin Glargine Sales Forecast by Application (2021-2026) & (M mL)
Table 65. Global Insulin Glargine Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Insulin Glargine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Insulin Glargine Revenue Market Share Forecast by Application (2021-2026)
Table 68. Sanofi-Aventis Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors
Table 69. Sanofi-Aventis Insulin Glargine Product Offered
Table 70. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2019-2021E)
Table 71. Sanofi-Aventis Main Business
Table 72. Sanofi-Aventis Latest Developments
Table 73. Ganlee Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors
Table 74. Ganlee Insulin Glargine Product Offered
Table 75. Ganlee Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2019-2021E)
Table 76. Ganlee Main Business
Table 77. Ganlee Latest Developments
Table 78. Biocon Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors
Table 79. Biocon Insulin Glargine Product Offered
Table 80. Biocon Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2019-2021E)
Table 81. Biocon Main Business
Table 82. Biocon Latest Developments
List of Figures
Figure 1. Picture of Insulin Glargine
Figure 2. Insulin Glargine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Glargine Sales Growth Rate 2016-2026 (M mL)
Figure 7. Global Insulin Glargine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Insulin Glargine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global Insulin Glargine Sales Market Share by Type in 2020
Figure 12. Global Insulin Glargine Revenue Market Share by Type (2016-2021)
Figure 13. Insulin Glargine Consumed in Treat Type2 Diabetes
Figure 14. Global Insulin Glargine Market: Treat Type2 Diabetes (2016-2021) & (M mL)
Figure 15. Insulin Glargine Consumed in Treat Type1 Diabetes
Figure 16. Global Insulin Glargine Market: Treat Type1 Diabetes (2016-2021) & (M mL)
Figure 17. Global Insulin Glargine Sales Market Share by Application (2016-2021)
Figure 18. Global Insulin Glargine Revenue Market Share by Application in 2020
Figure 19. Global Insulin Glargine Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Insulin Glargine Revenue Market Share by Company in 2020
Figure 21. Global Insulin Glargine Sales Market Share by Regions (2016-2021)
Figure 22. Global Insulin Glargine Revenue Market Share by Region in 2020
Figure 23. Americas Insulin Glargine Sales 2016-2021 (M mL)
Figure 24. Americas Insulin Glargine Revenue 2016-2021 ($ Millions)
Figure 25. APAC Insulin Glargine Sales 2016-2021 (M mL)
Figure 26. APAC Insulin Glargine Revenue 2016-2021 ($ Millions)
Figure 27. Europe Insulin Glargine Sales 2016-2021 (M mL)
Figure 28. Europe Insulin Glargine Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Insulin Glargine Sales 2016-2021 (M mL)
Figure 30. Middle East & Africa Insulin Glargine Revenue 2016-2021 ($ Millions)
Figure 31. Americas Insulin Glargine Sales Market Share by Country in 2020
Figure 32. Americas Insulin Glargine Revenue Market Share by Country in 2020
Figure 33. Americas Insulin Glargine Sales Market Share by Type in 2020
Figure 34. Americas Insulin Glargine Sales Market Share by Application in 2020
Figure 35. United States Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Insulin Glargine Sales Market Share by Region in 2020
Figure 40. APAC Insulin Glargine Revenue Market Share by Regions in 2020
Figure 41. APAC Insulin Glargine Sales Market Share by Type in 2020
Figure 42. APAC Insulin Glargine Sales Market Share by Application in 2020
Figure 43. China Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Insulin Glargine Sales Market Share by Country in 2020
Figure 50. Europe Insulin Glargine Revenue Market Share by Country in 2020
Figure 51. Europe Insulin Glargine Sales Market Share by Type in 2020
Figure 52. Europe Insulin Glargine Sales Market Share by Application in 2020
Figure 53. Germany Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Insulin Glargine Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Insulin Glargine Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Insulin Glargine Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Insulin Glargine Sales Market Share by Application in 2020
Figure 62. Egypt Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Insulin Glargine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
